Literature DB >> 3015516

Raising antibodies by coupling peptides to PPD and immunizing BCG-sensitized animals.

P J Lachmann, L Strangeways, A Vyakarnam, G Evan.   

Abstract

The use of PPD (purified protein derivative of tuberculin) as a carrier has several significant advantages. It provides very powerful T cell help and it gives rise to virtually no antibody response against itself. This is particularly useful if it is intended to go on to make monoclonal antibodies, where the presence of a large amount of anti-carrier antibody is a nuisance! Furthermore, unlike most comparably powerful adjuvant systems, it can be used in man. PPD coupling has been used to raise antibodies to haptens and to raise T cell responses to tumour cells. It is here reported that small peptides coupled to PPD will give rise to good titres of anti-peptide antibody. For peptides that contain no cysteine, coupling has been achieved by attaching succinimidyl 4-(N-maleimidomethyl) cyclohexane-1-carboxylate (SMCC) to the alpha-amino group of the peptide and N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP) to the PPD and allowing an uncleavable bond to form between them. Data on immunization with the leucotactic nonapeptide of the alpha chain of the complement component C3 and with some oncogene-related peptides have been obtained.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3015516     DOI: 10.1002/9780470513286.ch3

Source DB:  PubMed          Journal:  Ciba Found Symp        ISSN: 0300-5208


  20 in total

1.  Evidence that down-regulation of beta-cell glucose transporters in non-insulin-dependent diabetes may be the cause of diabetic hyperglycemia.

Authors:  L Orci; M Ravazzola; D Baetens; L Inman; M Amherdt; R G Peterson; C B Newgard; J H Johnson; R H Unger
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

2.  Cloning and expression of a widely distributed (type IV) adenylyl cyclase.

Authors:  B N Gao; A G Gilman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

3.  Subpopulations of proteasomes in rat liver nuclei, microsomes and cytosol.

Authors:  A Palmer; A J Rivett; S Thomson; K B Hendil; G W Butcher; G Fuertes; E Knecht
Journal:  Biochem J       Date:  1996-06-01       Impact factor: 3.857

4.  Ca2+/calcineurin-inhibited adenylyl cyclase, highly abundant in forebrain regions, is important for learning and memory.

Authors:  F A Antoni; M Palkovits; J Simpson; S M Smith; A L Leitch; R Rosie; G Fink; J M Paterson
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

5.  Substrate-induced regulation of the human colonic monocarboxylate transporter, MCT1.

Authors:  Mark A Cuff; Daniel W Lambert; Soraya P Shirazi-Beechey
Journal:  J Physiol       Date:  2002-03-01       Impact factor: 5.182

6.  Amino acid sequence and the cellular location of the Na(+)-dependent D-glucose symporters (SGLT1) in the ovine enterocyte and the parotid acinar cell.

Authors:  P S Tarpey; I S Wood; S P Shirazi-Beechey; R B Beechey
Journal:  Biochem J       Date:  1995-11-15       Impact factor: 3.857

7.  CTCF, a conserved nuclear factor required for optimal transcriptional activity of the chicken c-myc gene, is an 11-Zn-finger protein differentially expressed in multiple forms.

Authors:  E M Klenova; R H Nicolas; H F Paterson; A F Carne; C M Heath; G H Goodwin; P E Neiman; V V Lobanenkov
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

Review 8.  Immunity, autoimmunity and immunotherapy: new frontiers in heat shock protein research.

Authors:  C J Elson; S J Thompson
Journal:  Clin Exp Immunol       Date:  1994-11       Impact factor: 4.330

9.  Induction of an auto-anti-IgE response in rats. IV. Effects on mast cell degranulation.

Authors:  G Jaffery; E B Bell; J W Coleman
Journal:  Immunology       Date:  1993-04       Impact factor: 7.397

10.  Regulation of the ovine intestinal Na+/glucose co-transporter (SGLT1) is dissociated from mRNA abundance.

Authors:  L Lescale-Matys; J Dyer; D Scott; T C Freeman; E M Wright; S P Shirazi-Beechey
Journal:  Biochem J       Date:  1993-04-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.